Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.
AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") today reported financial and operating results for the quarter ended September 30, 2025. "AllianceBernstein's strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback